Knowledge is essential for so many human activities and values, including freedom, the exercise of political power, and economic, social and personal development. Patents, copyright laws and other regulations and economic systems that concern the creation, management and governance of… Continue Reading
The following are cases in the United States wherein compulsory licensing as a limitation on the remedies for infringement (Trips Article 44 cases) relating to medical technologies. 2012: Conceptus, Inc. v. Hologic, Inc. Conceptus, inc. filed a patent infringement case… Continue Reading
(More on compulsory licensing here.) This is a non-exhaustive set of provisions in US statutes that are used to for non-voluntary use of patented inventions. 28 U.S.C. 1498 – Patent and copyright cases (a) Whenever an invention described in and… Continue Reading
Global norms on compulsory licensing Country experiences Compulsory licensing in the United States Statutory authority for compulsory licenses on patents in the United States Compulsory licensing as a remedy to anticompetitive practices Compulsory licensing under the Bayh-Dole Act Compulsory licensing… Continue Reading
Knowledge Ecology International and 43 other health-care interested groups are calling on Congress to pass the CREATES Act. The CREATES Act, or the “Creating and Restoring Equal Access To Equivalent Samples Act of 2017”, is a bipartisan proposal to speed… Continue Reading
November 14 to November 18, 2016 WIPO’s Page for the Meeting SCCR 33: Argentina, Colombia and Mexico – Note on the Draft Treaty to Protect Broadcasting Organizations SCCR33: Opening statement of the Asia Pacific Group (delivered by India) SCCR 33.… Continue Reading
This does not yet have links to the TPP11 negotiations and agreement, after the US left. The May 11, 2015 consolidated text on the Intellectual Property Chapter of the TPP, with country positions. August 4, 2015 Press Release The May… Continue Reading
The USTR’s Special 301 Report has been issued every year beginning in 1989. The Executive Summary of the 2009 report says: The “Special 301” Report is an annual review of the global state of intellectual property rights (IPR) protection and… Continue Reading
More on Fabry here: https://keionline.org/fabry NIH rejects Fabrazyme March-In Petition December 7, 2010. Press release from Fabry patients: DHHS denies patient’s march-in request to end Genzyme’s rationing of treatment for Fabry Disease citing that FDA rules block manufactures from supplying… Continue Reading
(More on government funded inventions here: https://keionline.org/government-funded-inventions) On December 9, 2016, the U.S. Army announced its intent to grant an exclusive license to Sanofi on patents for a U.S. Army-developed Zika vaccine. KEI and various other non-profit groups have filed… Continue Reading